MedTrace Logo

Physician Acceptance of the NeuTrace System for Cardiac Electroanatomic Mapping

NCT05214170 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-04-07

No results posted yet for this study

Summary

The trial is a prospective, non-randomized, single-arm feasibility trial to evaluate physician acceptance of the NeuTrace System v1.0 for cardiac electroanatomic mapping.

Conditions

Interventions

DEVICE

Electroanatomic mapping with the NeuTrace System

Patients with arrhythmias undergo electroanatomic mapping with the NeuTrace System.

Sponsors & Collaborators

  • NeuTrace, Inc.

    lead INDUSTRY

Principal Investigators

  • Gediminas Rackauskas, MD · Vilnius University Hospital Santaros Klinikos

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-07
Primary Completion
2024-05-07
Completion
2024-06-07

Countries

  • Lithuania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05214170 on ClinicalTrials.gov